Matches in SemOpenAlex for { <https://semopenalex.org/work/W2916115362> ?p ?o ?g. }
- W2916115362 endingPage "4295" @default.
- W2916115362 startingPage "4276" @default.
- W2916115362 abstract "The lipid-activated G protein-coupled receptor (GPCR) GPR55 has been proposed as a drug target for the treatment of chronic diseases including inflammation, neurodegeneration, neuropathic pain, metabolic diseases, and cancer. A series of chromen-4-one-2-carboxylic acid derivatives was synthesized with the aim to obtain potent and selective ligands for GPR55 by (i) attachment of a variety of substituted 8-benzamido residues, (ii) substitution in position 6 by halogen atoms, and (iii) thioation of the 4-oxo function. The compounds were investigated in β-arrestin recruitment assays using enzyme complementation. Depending on the substitution pattern, a spectrum of efficacies was obtained ranging from (partial) agonists to antagonists. 6-Chloro-8-(3-((5-cyclohexylpentyl)oxy)benzamido)-4-oxo-4H-chromene-2-carboxylic acid (74, PSB-18251) displayed the highest efficacy of the series combined with high potency (EC50 0.196 μM). 6-Chloro-8-(3-(heptyloxy)benzamido)-4-oxo-4H-chromene-2-carboxylic acid (76, PSB-18337) exhibited higher potency (EC50 0.0400 μM) but lower efficacy (39%). Several GPR55 antagonists were discovered including 8-(3-(cyclohexylmethoxy)benzamido)-4-oxo-4H-chromene-2-carboxylic acid (57, PSB-18263) (IC50 8.23 μM) and 4-oxo-8-(3-phenethoxybenzamido)-4H-chromene-2-carboxylic acid (65, PSB-18270) (IC50 3.96 μM). These potent GPR55 agonists and antagonists showed high selectivity versus the related GPCRs GPR18 and GPR35 tested in the same assay system, while 8-(4-(4-cyclohexylbutoxy)benzamido)-6-fluoro-4-oxo-4H-chromene-2-carboxylic acid (84, PSB-18177) represents a dual GPR35/GPR55 antagonist (IC50 GPR55: 3.26 μM, GPR35: 2.57 μM). Binding studies of selected compounds at CB1 and CB2 receptors indicated GPR55 selectivity also versus CB receptors. The newly developed GPR55 (partial) agonists and antagonists will be useful tools for evaluating the suitability of GPR55 as a drug target." @default.
- W2916115362 created "2019-03-02" @default.
- W2916115362 creator A5001701871 @default.
- W2916115362 creator A5017915434 @default.
- W2916115362 creator A5036369389 @default.
- W2916115362 creator A5044861981 @default.
- W2916115362 creator A5053693080 @default.
- W2916115362 creator A5074577709 @default.
- W2916115362 creator A5075621121 @default.
- W2916115362 date "2019-02-26" @default.
- W2916115362 modified "2023-09-23" @default.
- W2916115362 title "Development of Chromen-4-one Derivatives as (Ant)agonists for the Lipid-Activated G Protein-Coupled Receptor GPR55 with Tunable Efficacy" @default.
- W2916115362 cites W1527357181 @default.
- W2916115362 cites W1557215935 @default.
- W2916115362 cites W1887249759 @default.
- W2916115362 cites W1971726942 @default.
- W2916115362 cites W1973911198 @default.
- W2916115362 cites W1982830863 @default.
- W2916115362 cites W1989397655 @default.
- W2916115362 cites W1994513849 @default.
- W2916115362 cites W2004468399 @default.
- W2916115362 cites W2008357099 @default.
- W2916115362 cites W2008966834 @default.
- W2916115362 cites W2009659223 @default.
- W2916115362 cites W2015263236 @default.
- W2916115362 cites W2028491124 @default.
- W2916115362 cites W2029101269 @default.
- W2916115362 cites W2035968282 @default.
- W2916115362 cites W2043889413 @default.
- W2916115362 cites W2047132085 @default.
- W2916115362 cites W2056927905 @default.
- W2916115362 cites W2059191280 @default.
- W2916115362 cites W2060837509 @default.
- W2916115362 cites W2072840386 @default.
- W2916115362 cites W2074631079 @default.
- W2916115362 cites W2080032386 @default.
- W2916115362 cites W2084445932 @default.
- W2916115362 cites W2091057846 @default.
- W2916115362 cites W2109014958 @default.
- W2916115362 cites W2112755850 @default.
- W2916115362 cites W2139870433 @default.
- W2916115362 cites W2143150187 @default.
- W2916115362 cites W2148626765 @default.
- W2916115362 cites W2151109262 @default.
- W2916115362 cites W2163573952 @default.
- W2916115362 cites W2184312579 @default.
- W2916115362 cites W2258638067 @default.
- W2916115362 cites W2328764258 @default.
- W2916115362 cites W2330909513 @default.
- W2916115362 cites W2331963514 @default.
- W2916115362 cites W2462705062 @default.
- W2916115362 cites W2514349785 @default.
- W2916115362 cites W2558217333 @default.
- W2916115362 cites W2605767320 @default.
- W2916115362 cites W2620296850 @default.
- W2916115362 cites W2753262550 @default.
- W2916115362 cites W2773114504 @default.
- W2916115362 cites W2773362875 @default.
- W2916115362 cites W2791482559 @default.
- W2916115362 cites W2808421575 @default.
- W2916115362 cites W2829010409 @default.
- W2916115362 cites W2884803754 @default.
- W2916115362 cites W4249513405 @default.
- W2916115362 doi "https://doi.org/10.1021/acsomega.8b03695" @default.
- W2916115362 hasPublicationYear "2019" @default.
- W2916115362 type Work @default.
- W2916115362 sameAs 2916115362 @default.
- W2916115362 citedByCount "7" @default.
- W2916115362 countsByYear W29161153622020 @default.
- W2916115362 countsByYear W29161153622022 @default.
- W2916115362 countsByYear W29161153622023 @default.
- W2916115362 crossrefType "journal-article" @default.
- W2916115362 hasAuthorship W2916115362A5001701871 @default.
- W2916115362 hasAuthorship W2916115362A5017915434 @default.
- W2916115362 hasAuthorship W2916115362A5036369389 @default.
- W2916115362 hasAuthorship W2916115362A5044861981 @default.
- W2916115362 hasAuthorship W2916115362A5053693080 @default.
- W2916115362 hasAuthorship W2916115362A5074577709 @default.
- W2916115362 hasAuthorship W2916115362A5075621121 @default.
- W2916115362 hasBestOaLocation W29161153621 @default.
- W2916115362 hasConcept C135285700 @default.
- W2916115362 hasConcept C170493617 @default.
- W2916115362 hasConcept C185592680 @default.
- W2916115362 hasConcept C202751555 @default.
- W2916115362 hasConcept C2777752497 @default.
- W2916115362 hasConcept C2778938600 @default.
- W2916115362 hasConcept C2779074116 @default.
- W2916115362 hasConcept C55493867 @default.
- W2916115362 hasConcept C57992300 @default.
- W2916115362 hasConcept C71240020 @default.
- W2916115362 hasConcept C86803240 @default.
- W2916115362 hasConcept C98274493 @default.
- W2916115362 hasConceptScore W2916115362C135285700 @default.
- W2916115362 hasConceptScore W2916115362C170493617 @default.
- W2916115362 hasConceptScore W2916115362C185592680 @default.
- W2916115362 hasConceptScore W2916115362C202751555 @default.
- W2916115362 hasConceptScore W2916115362C2777752497 @default.
- W2916115362 hasConceptScore W2916115362C2778938600 @default.